PROGENICS PHARMACEUTICALS INC·4

Feb 17, 6:27 PM ET

PROGENICS PHARMACEUTICALS INC 4

4 · PROGENICS PHARMACEUTICALS INC · Filed Feb 17, 2005

Insider Transaction Report

Form 4
Period: 2005-01-01
PRENTKI RONALD J
DirectorPresident
Transactions
  • Award

    Employee Stock Options (Right to buy)

    2005-01-01+2,1332,133 total
    Exercise: $17.16From: 2005-04-01Exp: 2005-07-01Common Stock (2,133 underlying)
  • Exercise/Conversion

    Common Stock, par value $.0013

    2005-01-03$16.79/sh+110$1,84733,539 total
Footnotes (1)
  • [F1]The exercise price per share for each option shall be the lesser of this amount or 85% of the fair market value of the Common Stock on the date of exercise.

Documents

1 file
  • 4
    b404828_ex.xmlPrimary

    FORM 4